RE: [External email] Sad news about Dr. Ludden
Public
Dear All,
I am extremely saddened to hear this news. As mentioned by Ene, Dr. Tom Ludden
was one of the pioneers in advancing pharmacometrics along with Dr. Beal and
Dr. Sheiner promoting its value and impact in drug discovery and development as
well as acceptance by the FDA. He provided invaluable scientific advice and
trained numerous scientists in pharmacometrics. He was a real gentle soul and
it was truly a privilege to have known him and be tutored by him.
May his soul rest in peace.
Sincerely,
Bela
Quoted reply history
From: [email protected] <[email protected]> On Behalf Of
ENE ETTE
Sent: Friday, August 2, 2024 5:30 PM
To: Diane Mould <[email protected]>; Riley, Steve <[email protected]>;
[email protected]
Subject: RE: [External email][NMusers] Sad news about Dr. Ludden
Some people who received this message don't often get email from
[email protected]<mailto:[email protected]>. Learn why this is
https://aka.ms/LearnAboutSenderIdentification
EXTERNAL EMAIL– Use caution with any links or file attachments.
Dear All:
In Dr. Ludden we lost an excellent scientist who helped to revolutionize and
advance clinical pharmacokinetics, pharmacometrics, clinical pharmacology, and
drug development. I’m indebted to him for the impact he made on my life as a
pharmacometrician, clinical pharmacologist, and drug developer while working
with him at the FDA. He started the Pharmacometrics Staff Unit which became
Pharmacometrics Division in later years.
May his soul rest in peace.
Sincerely,
Ene.
Sent from https://go.microsoft.com/fwlink/?LinkId=550986 for Windows
From: Diane Mould<mailto:[email protected]>
Sent: Friday, August 2, 2024 4:03 PM
To: Riley, Steve<mailto:[email protected]>;
[email protected]<mailto:[email protected]>
Subject: RE: [External email][NMusers] Sad news about Dr. Ludden
Dear All
I am very saddened to hear this news. Tom Ludden was one of the nicest and
smartest people that I have ever known. He was a gentle giant in our field and
I will miss him.
Best
Diane
From: [email protected]<mailto:[email protected]>
<[email protected]<mailto:[email protected]>> On Behalf
Of Riley, Steve
Sent: Friday, August 2, 2024 2:41 PM
To: [email protected]<mailto:[email protected]>
Subject: [External email][NMusers] Sad news about Dr. Ludden
CAUTION: This email originated from outside the organization. Do not click
links or open attachments unless you recognize the sender and know the content
is safe.
Dear NM-Users,
Regrettably, I am writing to let you know that Dr. Ludden passed away Tuesday
evening, 30JUL2024.
I was able to get there over the weekend prior to visit him and his family.
During his wakeful moments we had some good scientific discussions.
We talked a lot about NONMEM and how its functionality and utility has expanded
since he retired. He was pleased to hear about the changes.
He was surrounded by family for the days leading up to the end. They were all
appreciative that I was able to get there and tell him (and them) how much he
meant to all of us and the impact he had on our careers.
I think memories of Dr. Ludden were characterized perfectly by Marc Gastonguay,
“I am forever grateful for the positive impact that Tom had on my life and
career, not to mention the tremendous, although often underappreciated,
contributions he made to the disciplines of clinical pharmacology and
pharmacometrics. His humble brilliance will be missed and fondly remembered.”
Steve Riley
This e-mail message, together with any attachments, contains information of
Merck & Co., Inc. (126 East Lincoln Ave., P.O. Box 2000, Rahway, NJ USA 07065)
and/or its affiliates, that may be confidential, proprietary copyrighted and/or
legally privileged. (Direct contact information for affiliates is available
at - Contact us - https://www.msd.com/contact-us/.) It is intended solely
for the use of the individual or entity named on this message. If you are not
the intended recipient, and have received this message in error, please notify
us immediately by reply e-mail and then delete it from your system.